Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis.

N.P. Juffermans*, A. Verbon, S.J. van Deventer, W.A. Buurman, H. van Deutekom, P. Speelman, T. van der Poll

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Laboratory of Experimental Internal Medicine, Department of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands.

Lipopolysaccharide (LPS) is the principal stimulator of host defense against gram-negative bacteria. LPS-binding protein (LBP), bactericidal/permeability-increasing protein (BPI), and soluble CD14 (sCD14) bind LPS and regulate its toxicity. Lipoarabinomannan, a cell wall component of Mycobacterium tuberculosis, resembles LPS with respect to induction of inflammatory responses through recognition by LBP and sCD14. LBP, BPI, and sCD14 were measured in serum of 124 patients with tuberculosis in various stages of disease, in persons who had been in close contact with patients with contagious pulmonary tuberculosis, and in healthy controls. Levels of these LPS toxicity-regulating proteins were elevated in patients with active tuberculosis compared with those in contacts and controls and declined during treatment. The levels of LBP and sCD14 were higher in patients with fever and anorexia. LPS-regulating proteins may play a role in host defense during tuberculosis, presumably through interaction with lipoarabinomannan.
Original languageEnglish
Pages (from-to)1839-1842
Number of pages3
JournalJournal of Infectious Diseases
Issue number6
Publication statusPublished - 1 Jan 1998

Cite this